-----------------------------------------------------------

NMP-2007-1.2-3 Analysis of the ethical, regulatory, social and economic environment of nanomedicine
Technical content / scope: Nanotechnology will have a large impact on medicine and will add a new dimension to many ethical, regulatory, social and economic issues in this area. This support action should make a survey of existing relevant documents in the field, analyse the implications above looking at mid to long-term impacts of nanomedicine and foresee scenarios on the possible consequences for the citizens, society, economics and social structures, including costs of future health care (foresight). A “round table” involving scientists, experts on ethical, regulatory, social and economic issues, patient groups, regulatory agencies, health insurance, policy makers and company representatives should be established based upon existing activities. With a view of contributing to future strategic decisions responsive to the needs of all stakeholders, the round table will help to define the requirements of the patient and society as well as the regulatory, social and targeted communication frameworks, which will be an important requirement for successfully introducing new nanomedical innovations to the market. Conclusions should be drawn and recommendations should be issued.
Funding scheme: Coordination and support actions aiming at supporting research activities.
Specific features: Maximum duration: 12 months. Gender issues should be considered.
Expected impact: (i) Support to stakeholders’ decision making concerning nanomedicine: public authorities, industry, researchers and citizens; (ii) support to good governance in nanotechnology; (iii) support to the safe, integrated and responsible approach as laid down in "Nanosciences and Nanotechnologies: An action plan for Europe".